Skip to main content
Danny Landau, MD, Oncology, Orlando, FL

DannyALandauMD

Oncology Orlando, FL

Physician

Dr. Landau is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Landau's full profile

Already have an account?

Education & Training

  • Orlando Health
    Orlando HealthFellowship, Hematology and Medical Oncology, 2008 - 2011
  • University of South Florida Morsani
    University of South Florida MorsaniResidency, Internal Medicine, 2005 - 2008
  • University of South Florida College of Medicine
    University of South Florida College of MedicineClass of 2005

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2023 - 2025
  • ND State Medical License
    ND State Medical License 2024 - 2025
  • SC State Medical License
    SC State Medical License 2023 - 2025
  • FL State Medical License
    FL State Medical License 2006 - 2025
  • PA State Medical License
    PA State Medical License 2023 - 2024
  • RI State Medical License
    RI State Medical License 2023 - 2024
  • ME State Medical License
    ME State Medical License 2023 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Insights into Hematopoietic Stem Cell Origin, Differentiation and Malignancy Provided by Single Cell Approaches 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Continuing Conversations With the Speakers on Insights into Hematopoietic Stem Cell Origin, Differentiation and Malignancy Provided by Single Cell Approaches 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • The internet bias toward nontraditional first line prostate cancer treatments. 
    2019 ASCO Annual Meeting - 6/1/2019